Journal article Open Access

Radiolabeled Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitors: (Radio)Syntheses and in Vitro and First in Vivo Evaluation.

Hugenberg, Verena; Wagner, Stefan; Kopka, Klaus; Schäfers, Michael; Schuit, Robert C; Windhorst, Albert D; Hermann, Sven


Dublin Core Export

<?xml version='1.0' encoding='utf-8'?>
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Hugenberg, Verena</dc:creator>
  <dc:creator>Wagner, Stefan</dc:creator>
  <dc:creator>Kopka, Klaus</dc:creator>
  <dc:creator>Schäfers, Michael</dc:creator>
  <dc:creator>Schuit, Robert C</dc:creator>
  <dc:creator>Windhorst, Albert D</dc:creator>
  <dc:creator>Hermann, Sven</dc:creator>
  <dc:date>2017-01-12</dc:date>
  <dc:description>The noninvasive imaging of MMP activity in vivo could have a
high impact in basic research as well as in clinical applications. This approach
can be established using radiolabeled MMP inhibitors (MMPIs) as tracers for
the detection of activated MMPs by means of PET. However, the complexity of
diseases associated with dysregulated MMP expression necessitates the imaging
of distinct MMPs or MMP subgroups to distinguish their individual role in
specific diseases. To this end, selective and potent MMP-13 inhibitors based on
a N,N′-bis(benzyl)pyrimidine-4,6-dicarboxamide core have been synthesized
and successfully radiolabeled with carbon-11, fluorine-18, and gallium-68.
Selected radiolabeled candidates were evaluated in vitro and in vivo regarding
their pharmacokinetic properties and metabolic stability.</dc:description>
  <dc:identifier>https://zenodo.org/record/478813</dc:identifier>
  <dc:identifier>10.1021/acs.jmedchem.6b01284</dc:identifier>
  <dc:identifier>oai:zenodo.org:478813</dc:identifier>
  <dc:relation>info:eu-repo/grantAgreement/EC/FP7/278850/</dc:relation>
  <dc:relation>url:https://zenodo.org/communities/ecfunded</dc:relation>
  <dc:relation>url:https://zenodo.org/communities/inmind</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>http://creativecommons.org/licenses/by/4.0/legalcode</dc:rights>
  <dc:source>J. Med. Chem. 60(1) 307–321</dc:source>
  <dc:subject>Selective matrix metalloproteinase inhibitors</dc:subject>
  <dc:subject>selective MMP-13 inhibitors</dc:subject>
  <dc:subject>positron emission tomography</dc:subject>
  <dc:subject>radiotracer</dc:subject>
  <dc:title>Radiolabeled Selective Matrix Metalloproteinase 13 (MMP-13) Inhibitors: (Radio)Syntheses and in Vitro and First in Vivo Evaluation.</dc:title>
  <dc:type>info:eu-repo/semantics/article</dc:type>
  <dc:type>publication-article</dc:type>
</oai_dc:dc>
12
60
views
downloads
Views 12
Downloads 60
Data volume 117.7 MB
Unique views 12
Unique downloads 58

Share

Cite as